Yuesai Biotechnology

Yuesai Biotechnology is a new-generation cell therapy drug developer, focusing on the development of a new generation of cell therapy drugs.

Number of Funding Rounds

Total Funding Amount

1

¥200M

Yuesai Biotechnology has raised a total of ¥200M in funding over 2 rounds. Their latest funding was raised on Mar 14, 2022 from a Seed round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Mar 14, 2022	Seed	¥200M	1	—	—	Detail

Number of Lead Investors

Number of Investors

—

1

Yuesai Biotechnology is funded by 1 investors. Ruihua Venture Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
Ruihua Venture Capital	—	Seed